Patterns of Focal Amyloid Deposition Using <sup>18</sup>F-Florbetaben PET in Patients with Cognitive Impairment

Patterns of Focal Amyloid Deposition Using <sup>18</sup>F-Florbetaben PET in Patients with Cognitive Impairment

Accumulation of aggregated amyloid-<inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mi mathvariant="sans-serif">β</mi></semantics></math></inline-formula> (A<inline-formula&g...

Full description

Bibliographic Details
Main Authors:	Sung-eun Chung, Hyung-Ji Kim, Sungyang Jo, Sunju Lee, Yoojin Lee, Jee Hoon Roh, Jae-Hong Lee
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Series:	Diagnostics
Subjects:	Alzheimer’s disease amyloid beta 42 conditional probability
Online Access:	https://www.mdpi.com/2075-4418/12/6/1357

Similar Items

Alterations in Gut Microbiota and Their Correlation with Brain Beta-Amyloid Burden Measured by <sup>18</sup>F-Florbetaben PET in Mild Cognitive Impairment Due to Alzheimer’s Disease
by: Geon Ha Kim, et al.
Published: (2024-03-01)

18F-Florbetaben Amyloid PET Imaging: A Chinese Study in Cognitive Normal Controls, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
by: Yan Chang, et al.
Published: (2020-07-01)

Clinical Relevance of [<sup>18</sup>F]Florbetaben and [<sup>18</sup>F]FDG PET/CT Imaging on the Management of Patients with Dementia
by: Damiano Librizzi, et al.
Published: (2021-02-01)

Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
by: Caterina Motta, et al.
Published: (2023-08-01)

18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition
by: Lucia Baratto, et al.
Published: (2018-07-01)

<sup>18</sup>F–THK–5351, Fluorodeoxyglucose, and Florbetaben PET Images in Atypical Alzheimer’s Disease: A Pictorial Insight into Disease Pathophysiology
by: Sohee Park, et al.
Published: (2021-04-01)

A simple and efficient automated microvolume radiosynthesis of [18F]Florbetaben
by: Ksenia Lisova, et al.
Published: (2020-12-01)

Generation of Conventional <sup>18</sup>F-FDG PET Images from <sup>18</sup>F-Florbetaben PET Images Using Generative Adversarial Network: A Preliminary Study Using ADNI Dataset
by: Hyung Jin Choi, et al.
Published: (2023-07-01)

High Correlation of Static First-Minute-Frame (FMF) PET Imaging after <sup>18</sup>F-Labeled Amyloid Tracer Injection with [<sup>18</sup>F]FDG PET Imaging
by: Alexander P. Seiffert, et al.
Published: (2021-07-01)

Texture-Based Analysis of <sup>18</sup>F-Labeled Amyloid PET Brain Images
by: Alexander P. Seiffert, et al.
Published: (2021-02-01)

Visualization of Dialysis-Related Amyloid Arthropathy on <sup>18</sup>F-FDG PET-CT Scan
by: Miju Cheon, et al.
Published: (2022-01-01)

Evaluation of BCG Vaccination and Plasma Amyloid: A Prospective, Pilot Study with Implications for Alzheimer’s Disease
by: Coad Thomas Dow, et al.
Published: (2022-02-01)

P‐tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status
by: Michelle R. Campbell, et al.
Published: (2021-01-01)

Activated gliosis, accumulation of amyloid β, and hyperphosphorylation of tau in aging canines with and without cognitive decline
by: Amelia D. Hines, et al.
Published: (2023-04-01)

Amyloid beta plaque accumulation with longitudinal [18F]AZD4694 PET
by: Joseph Therriault, et al.
Published: (2023-07-01)

The impact of subthreshold levels of amyloid deposition on conversion to dementia in patients with amyloid-negative amnestic mild cognitive impairment
by: Hyung-Ji Kim, et al.
Published: (2022-07-01)

Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases
by: Sonja Daerr, et al.
Published: (2017-01-01)

Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies
by: Fiona Heeman, et al.
Published: (2019-03-01)

Non-invasive quantification of 18F-florbetaben with total-body EXPLORER PET
by: Emily Nicole Holy, et al.
Published: (2024-04-01)

Automated spatial brain normalization and hindbrain white matter reference tissue give improved [18F]-florbetaben PET quantitation in Alzheimer´s model mice
by: Felix eOverhoff, et al.
Published: (2016-02-01)

Predicting amyloid PET positivity using plasma p‐tau181 and other blood‐based biomarkers
by: Hyuk Sung Kwon, et al.
Published: (2023-10-01)

False Memory and Alzheimer’s Disease Pathology in Patients with Amnestic Mild Cognitive Impairment: A Study with Amyloid PET
by: Eun-Ji Choi, et al.
Published: (2021-06-01)

The HSP40 chaperone Ydj1 drives amyloid beta 42 toxicity
by: Julia Ring, et al.
Published: (2022-05-01)

Amyloid proteins : methods and protocols /
by: Sigurdsson, Einar M.
Published: (2005)

Obstructive sleep apnea and amyloid-β42 in adolescents: The results of a pilot study
by: O. N. Berdina, et al.
Published: (2022-07-01)

Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET
by: Si Eun Kim, et al.
Published: (2020-01-01)

Development of a Low-Molecular-Weight Aβ42 Detection System Using a Enzyme-Linked Peptide Assay
by: Sang-Heon Kim, et al.
Published: (2021-12-01)

Amyloid β-Oligomers Inhibit the Nuclear Ca<sup>2+</sup> Signals and the Neuroprotective Gene Expression Induced by Gabazine in Hippocampal Neurons
by: Pedro Lobos, et al.
Published: (2023-11-01)

Computational modeling of the effects of amyloid-beta on release probability at hippocampal synapses
by: Armando eRomani, et al.
Published: (2013-01-01)

Development of Amyloid PET Analysis Pipeline Using Deep Learning-Based Brain MRI Segmentation—A Comparative Validation Study
by: Jiyeon Lee, et al.
Published: (2022-03-01)

BETA-AMYLOID AS PATHOGENESIS OF ALZHEIMER DISEASE
by: Kadek Ary Mahendri Pattni
Published: (2013-07-01)

Aβ42 as a Biomarker of Alzheimer’s Disease: Is Saliva a Viable Alternative to Cerebrospinal Fluid?
by: Silvia Boschi, et al.
Published: (2022-12-01)

A Positive Feedback Loop of Hippo- and c-Jun-Amino-Terminal Kinase Signaling Pathways Regulates Amyloid-Beta-Mediated Neurodegeneration
by: Madison Irwin, et al.
Published: (2020-03-01)

The effects of amyloid beta aggregation on neuronal transcription
by: Jesse St. Jean, et al.
Published: (2023-06-01)

Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus
by: Patel Sunil, et al.
Published: (2012-03-01)

Serum amyloid beta 42 levels correlated with metabolic syndrome and its components
by: Kecheng Li, et al.
Published: (2024-02-01)

Zn<sup>2+</sup> Interaction with Amyloid-B: Affinity and Speciation
by: Giuseppe Arena, et al.
Published: (2019-07-01)

Decrease in the production of beta-amyloid by berberine inhibition of the expression of beta-secretase in HEK293 cells
by: Zhu Feiqi, et al.
Published: (2011-12-01)

Elevated Plasma Oligomeric Amyloid β-42 Is Associated with Cognitive Impairments in Cerebral Small Vessel Disease
by: Wensheng Qu, et al.
Published: (2023-01-01)

Highly Sensitive Micropatterned Interdigitated Electrodes for Enhancing the Concentration Effect Based on Dielectrophoresis
by: Hye Jin Kim, et al.
Published: (2019-09-01)